Editorial: New molecular targets involved in lung adenocarcinoma.

Zhan, Xianquan; Li, Na

Zhan, Xianquan; Li, Na.

Afiliación

Zhan X; Medical Science and Technology Innovation Center, Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Li N; Medical Science and Technology Innovation Center, Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Front Endocrinol (Lausanne) ; 14: 1138849, 2023.

Article en En | MEDLINE | ID: mdl-36755924

Asunto(s)

Adenocarcinoma del Pulmón; Neoplasias Pulmonares; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/patología

Palabras clave

combination effects; integrative omics; lung adenocarcinoma; lung cancer; molecular targets; multiomics; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google